Arvinas Inc (NASDAQ: ARVN) kicked off on Tuesday, up 4.59% from the previous trading day, before settling in for the closing price of $7.4. Over the past 52 weeks, ARVN has traded in a range of $5.90-$34.11.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales drop of Healthcare Sector giant was -5.32%. While this was happening, its average annual earnings per share was recorded 46.81%. With a float of $63.77 million, this company’s outstanding shares have now reached $73.00 million.
Let’s determine the extent of company efficiency that accounts for 430 employees. In terms of profitability, gross margin is 99.23%, operating margin of -22.39%, and the pretax margin is -10.78%.
Arvinas Inc (ARVN) Breakdown of a Key Holders of the stock
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Arvinas Inc is 12.63%, while institutional ownership is 88.89%. The most recent insider transaction that took place on Jun 24 ’25, was worth 43,377. In this transaction Chief Financial Officer of this company sold 5,700 shares at a rate of $7.61, taking the stock ownership to the 164,401 shares. Before that another transaction happened on Jun 24 ’25, when Company’s Officer proposed sale 5,927 for $7.35, making the entire transaction worth $43,593.
Arvinas Inc (ARVN) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around 46.81% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -5.43% during the next five years compared to -5.32% drop over the previous five years of trading.
Arvinas Inc (NASDAQ: ARVN) Trading Performance Indicators
Take a look at Arvinas Inc’s (ARVN) current performance indicators. Last quarter, stock had a quick ratio of 4.58. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 3.51.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.08, a number that is poised to hit -0.94 in the next quarter and is forecasted to reach -3.15 in one year’s time.
Technical Analysis of Arvinas Inc (ARVN)
Looking closely at Arvinas Inc (NASDAQ: ARVN), its last 5-days average volume was 2.17 million, which is a drop from its year-to-date volume of 2.25 million. As of the previous 9 days, the stock’s Stochastic %D was 40.85%.
During the past 100 days, Arvinas Inc’s (ARVN) raw stochastic average was set at 12.71%, which indicates a significant decrease from 67.53% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 45.13% in the past 14 days, which was lower than the 141.61% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $7.45, while its 200-day Moving Average is $16.84. However, in the short run, Arvinas Inc’s stock first resistance to watch stands at $7.91. Second resistance stands at $8.08. The third major resistance level sits at $8.28. If the price goes on to break the first support level at $7.54, it is likely to go to the next support level at $7.34. Now, if the price goes above the second support level, the third support stands at $7.17.
Arvinas Inc (NASDAQ: ARVN) Key Stats
The company with the Market Capitalisation of 564.96 million has total of 72,991K Shares Outstanding. Its annual sales at the moment are 263,400 K in contrast with the sum of -198,900 K annual income. Company’s last quarter sales were recorded 188,800 K and last quarter income was 82,900 K.
